Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis

Abstract The role of pre-treatment HBV DNA levels on the prognosis of hepatitis B virus-related decompensated cirrhosis is unclear. This study investigated the effects of pre-treatment HBV DNA and other determinants on short-term and long-term survival of chronic hepatitis B (CHB) patients with deco...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, Shou-Wu Lee, Chung-Hsin Chang, Szu-Chia Liao, Yen-Chun Peng, Teng-Yu Lee, Tsai-Chung Li
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-01-01
Series:	Scientific Reports
Subjects:	Chronic hepatitis B Decompensated cirrhosis HBV DNA
Online Access:	https://doi.org/10.1038/s41598-024-84413-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study
by: Shanghao Liu, et al.
Published: (2024-11-01)

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
by: Yan Lan, et al.
Published: (2024-11-01)

Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study
by: Yinglun Li, et al.
Published: (2024-12-01)

Spleen stiffness measurements during recompensation in patients with acutely decompensated liver cirrhosis: preliminary findings of a pilot study
by: Dilan Elcin Gülcicegi, et al.
Published: (2024-11-01)

Predictive Factors and Nomogram for Spontaneous Bacterial Peritonitis in Decompensated Cirrhosis Among the Elderly
by: Yan F, et al.
Published: (2024-12-01)

IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE
by: Leticia Macedo EIFLER, et al.
Published: (2024-11-01)

Association of Systemic Inflammation Response Index with Short-Term All-Cause Mortality in Decompensated Liver Cirrhosis Patients
by: Cheng J, et al.
Published: (2024-11-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
by: Jung Hee Kim, et al.
Published: (2025-12-01)

Commonly encountered symptoms and their management in patients with cirrhosis
by: Cyriac Abby Philips
Published: (2024-11-01)

Ultrasound‐Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease
by: Juliana Gödiker, et al.
Published: (2024-12-01)

Real-world experience with long-term albumin in patients with cirrhosis and ascites
by: Enrico Pompili, et al.
Published: (2024-12-01)

Minimal hepatic encephalopathy - from cirrhosis to neurological disorders
by: Jakub Jarmołowicz, et al.
Published: (2024-12-01)

HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis
by: Yuanyuan Li, et al.
Published: (2024-11-01)

Infection with hepatitis C virus as a cause of cirrhosis – case study
by: Lidia Sierpińska, et al.
Published: (2025-01-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
by: Umar Hayat, et al.
Published: (2024-12-01)

Pathomorphology of severe Grade 3-4 hepatic encephalopathy in decompensated cirrhosis patients with acute-on-chronic liver failure
by: T.V. Shulyatnikova, et al.
Published: (2024-06-01)

Association between Hepatitis B virus infection and COVID-19: outcomes from clinical analysis and online survey from Beijing, China
by: Fei Lin, et al.
Published: (2024-12-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01)

Sodium-glucose cotransporter 2 inhibition in patients with liver cirrhosis and diabetes: a possible role in ascites control?
by: Aurelio Seidita, et al.
Published: (2024-11-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)

The role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in patients with compensated liver cirrhosis
by: Reem M. Sabry, et al.
Published: (2025-02-01)

Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications
by: V. T. Ivashkin, et al.
Published: (2022-03-01)

Fibrinogen dysfunction and fibrinolysis state in patients with hepatitis B-related cirrhosis
by: Yu Liu, et al.
Published: (2024-12-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01)

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
by: Giovana Paula Angelice, et al.
Published: (2024-10-01)

Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
by: Romina Salpini, et al.
Published: (2025-01-01)

A new prognostic model based on serum apolipoprotein AI in patients with HBV-ACLF and acutely decompensated liver cirrhosis
by: Ruidong Mo, et al.
Published: (2025-02-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Cytokines in Liver Cirrhosis (Their Importance in Assessing Activity and Decompensation)
by: G. K. Mirodzhov, et al.
Published: (2023-11-01)

Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination
by: Angela Domínguez, et al.
Published: (2024-11-01)

Mechanisms and implications of recompensation in cirrhosisKey points
by: Salvatore Piano, et al.
Published: (2024-12-01)

Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis
by: Shan Wang, et al.
Published: (2025-01-01)

The future of clinical trials of gut microbiome therapeutics in cirrhosisKeypoints
by: Patricia P. Bloom, et al.
Published: (2025-01-01)